Lv5
960 积分 2023-03-17 加入
TIL expansion with high dose IL-2 or low dose IL-2 with anti-CD3/anti-CD28 stimulation provides different quality of TIL-expanded T cell clones
5天前
已完结
Mechanisms of granule-dependent killing
13天前
已完结
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
14天前
已完结
T-cell Engagers in Prostate Cancer
14天前
已完结
In Silico Re-Optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure-Response Simulation
14天前
已完结
Restoring tumor antigenicity activates the “bystander” T cell immune cycle
15天前
已完结
Renaissance of antiviral CD8+ T cell immunity in vaccination and disease
17天前
已完结
Bystander T cells in cancer immunology and therapy
17天前
已完结
Intratumoral T cell activation kills tumors regardless of T cell specificity
17天前
已完结
The immune microenvironment of colorectal cancer
1个月前
已完结